Biomedicine · 2017 · 72 citations · 109 references
MedicineOncologyPharmacologyApoptosisChemotherapyOral OncologyApoptosis ResistanceCell Cycle PharmacologyCell-cycle DysregulationChemotherapy ResistanceCytotoxic ChemotherapyTherapeutic ResistanceCancer Cell Proliferation InhibitionCell Cycle AnalysisCell Cycle InhibitionCell Proliferation KineticsFlow Cytometric AnalysisG1 Phase ArrestMitochondria-dependent Cell DeathP21 Regulation
phase and triggering mitochondria-mediated apoptosis. Our results provide evidences to support the potentially therapeutic application of YC-1 on fighting against drug resistant oral cancer in the future.
109
YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1
Eui‐Ju Yeo, Yang‐Sook Chun, Y.-S. Cho et al. · JNCI Journal of the National Cancer Institute · 2003 · 475 citations
Medicine, Oncology, Pharmacology +14
Kuang‐Chi Lai, An‐Cheng Huang, Shu-Chun Hsu et al. · Journal of Agricultural and Food Chemistry · 2010 · 164 citations
Medicine, Oncology, Pharmacology +16